ethylisopropylamiloride has been researched along with Hypertrophy, Right Ventricular in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quinn, DA | 1 |
| Du, HK | 1 |
| Thompson, BT | 1 |
| Hales, CA | 1 |
1 other study available for ethylisopropylamiloride and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Amiloride analogs inhibit chronic hypoxic pulmonary hypertension.
Topics: Amiloride; Animals; Blood Pressure; Cell Division; Chronic Disease; Hematocrit; Hypertension, Pulmon | 1998 |